°
Ashburn

Latest News - #Pavel Volchkov

A virologist, said the beginning of mass vaccine COVID-19

The organization of mass production and manufacturing large quantities of vaccines against coronavirus infection COVID-19 in Russia will begin not earlier than in six months, said the head of the laboratory of genomic engineering, Moscow Institute of physics and technology (MIPT) Pavel Volchkov.

Earlier the defense Ministry reported that successfully completed phase clinical trials of vaccines against coronavirus infection COVID-19 with the participation of volunteers on the basis of the main military clinical hospital named after academician N. N. Burdenko joint with the National research centre of epidemiology and Microbiology named after N. F. Gamalei.

Scientists have learned about the threat of a malfunction of the immune system in people with coronavirus

Ill COVID-19 may have problems with immunity, is reported in the Preprint of the research scientists from the Institute of Virology of Wuhan on the portal medrxiv.

Lymphopenia, that is, temporary or persistent decrease of lymphocytes in the blood, is a typical symptom in patients with COVID-19.

The named place with an increased risk of infection with coronavirus

In areas with poor ventilation the maximum risk of infection of the coronavirus, said virologists and immunologists, the words of which reports the newspaper "Izvestia".

It is noted that the purpose of the room itself is as significant as the work of ventilation in it.

The expert said, someone should start vaccination from COVID-19

After completion of the test vaccine created by NIC of epidemiology and Microbiology named Gamalei and testing of the defense Ministry, it will first start to introduce people who are at risk, said the head of the laboratory of genomic engineering MIPT Pavel Volchkov.

The expert noted that now the vaccine trials are primarily conducted on military personnel in middle age, which is all right with health.

The expert told the participants vaccine from COVID-19

In the first phase of testing the vaccine COVID-19 involved a perfectly healthy military volunteers, said to RIA Novosti on Saturday, head of the laboratory of genomic engineering MIPT Pavel Volchkov.

Earlier, the volunteers who participate in clinical trials of the vaccine in the Main military clinical Burdenko hospital of the National research centre of epidemiology and Microbiology named Gamalei, said that do not feel any side effects from the vaccination.